Medicine and Dentistry
Malignant Neoplasm
100%
Oncology
41%
Overall Survival
35%
Clinician
33%
COVID-19
33%
Life Expectancy
33%
Advanced Cancer
33%
Neoadjuvant Chemotherapy
33%
Pancreas Cancer
33%
Pancreas Adenocarcinoma
33%
Oncologist
30%
Clinical Trial
24%
Attitude
19%
Immunotherapy
19%
Patient Experience
16%
Antiandrogen Therapy
16%
Enzalutamide
16%
Prostate Cancer
16%
Pleura Mesothelioma
16%
Castration Resistant Prostate Cancer
16%
Abiraterone Acetate
16%
Abiraterone
16%
Arabinoxylan
16%
Trametinib
16%
Sclerosing Cholangitis
16%
Chemotherapy
16%
Clusterin
16%
Custirsen
16%
Paracentesis
16%
Natriuretic Factor
16%
Pembrolizumab
16%
Mesothelioma
16%
Lung Cancer
16%
Surgery
16%
Paclitaxel
16%
Gemcitabine
16%
Supportive Care
16%
Progression Free Survival
14%
Patient-Reported Outcome
11%
Health Care
11%
Arm
11%
CD3 Antigen
10%
Survival Time
10%
Programmed Death 1 Ligand 1
8%
Survival Rate
8%
Neoplasm
8%
Thrombocytopenia
8%
Peroperative Complication
8%
Brain Metastasis
8%
Docetaxel
8%
Pharmacology, Toxicology and Pharmaceutical Science
Enzalutamide
50%
Prostate Cancer
50%
Overall Survival
24%
Antiandrogen
18%
Clusterin
16%
Trametinib
16%
Custirsen
16%
Abiraterone
16%
Abiraterone Acetate
16%
Pleura Mesothelioma
16%
Natriuretic Factor
16%
Ascites
16%
Mesothelioma
16%
Cabozantinib
16%
Nivolumab
16%
Sunitinib
16%
Renal Cell Carcinoma
16%
Diseases
13%
Docetaxel
11%
Liver Cirrhosis
11%
Deterioration
11%
Adverse Event
10%
Prostate Specific Antigen
9%
Peroperative Complication
8%
Brain Metastasis
8%
Respiratory Failure
8%
Thrombocytopenia
8%
Liver Dysfunction
8%
Progression Free Survival
7%
Cemiplimab
6%
Malignant Neoplasm
5%
Congestive Heart Failure
5%
Nursing and Health Professions
Malignant Neoplasm
67%
Oncologist
33%
Health Care Personnel
33%
Life Expectancy
33%
Advanced Cancer
33%
Pilot Study
16%
Immunotherapy
16%
Patient Education
16%
Virtual Reality
16%
Systematic Review
16%
Cancer Center
16%
Monoclonal Antibody
16%
Natriuretic Factor
16%
Ascites
16%
Paracentesis
16%
Quality of Life
11%
Survival Time
10%
Patient Decision Making
8%
Physician
8%
Rank Sum Test
8%
Elderly (Age Groups)
8%
Telehealth
8%
Side Effect
8%
Patient-Reported Outcome
5%
Surgical Oncologist
5%